From: A Phase I Trial of Pox PSA vaccines (PROSTVAC®-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in Patients with Prostate Cancer
Age (years)
n
10
Mean
69.6
Range
63–79
Race/Ethnicity
Caucasians
9
African Americans
1
Baseline PSA (ng/mL)
434
9–1424
Baseline Anti-Vaccinia Titer
700
200–1600